Skip to main navigation
Skip to search
Skip to main content
Columbia University Home
Help & FAQ
English
Français
Español
Home
Profiles
Research units
Research output
Equipment
Datasets
Projects & Clinical Trials
Activities
Prizes
Courses
Student theses
Search by expertise, name or affiliation
View Scopus Profile
Gen Li
Mailman School of Public Health
h-index
h10-index
h5-index
13281
Citations
31
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
13281
Citations
31
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
3616
Citations
17
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2018
2022
Research activity per year
Overview
Fingerprint
Network
Projects & Clinical Trials
(3)
Research output
(4)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Gen Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Allele
22%
Anticancer
34%
Binding Protein
22%
Bioinformatics
17%
BRD4
46%
Cancer Cell
14%
Carcinogenesis
17%
Cell Cycle
20%
Cell Growth
19%
Cell Proliferation
21%
Demethylase
14%
Deubiquitinating Enzyme
19%
down Regulation
20%
Enhancer Region
75%
Expression Quantitative Trait Loci
66%
Gene Control
13%
Gene Expression
100%
Gene Signature
14%
Genetic Determinism
25%
Genetic Divergence
69%
Genetic Regulation
21%
Genetic Variation
45%
Genetics
34%
Genome Wide Association Study
14%
Genomics
33%
Genotyping
58%
Immunity
22%
Lipid Metabolism
14%
Long Non-Coding RNA
34%
Microbiome
22%
Myc
17%
Myeloid
34%
Oncogene
14%
Overall Survival
21%
P53
22%
Programmed Cell Death
36%
Protease
15%
Rare Variant
24%
RNA
22%
RNA Sequence
41%
RNA Sequencing
30%
Small Hairpin RNA
14%
Taxon
14%
Transcription
17%
Transcription Factors
43%
Transcriptome
48%
Transcriptomics
37%
Ubiquitin
16%
Ubiquitination
26%
Western Blot
15%
Medicine and Dentistry
Acute Kidney Injury
22%
Acute Myeloid Leukemia
22%
Biological Marker
31%
Bladder
12%
Bladder Cancer
17%
Bladder Injury
11%
Bladder Tumor
25%
Breast Cancer
45%
Cell Growth
14%
Cell Line
12%
Cell Survival
13%
Cohort Analysis
22%
COVID-19
13%
Cystectomy
24%
Cystoscopy
12%
Diseases
22%
Enhancer Region
35%
Glucose Intolerance
11%
Gut Microbiome
22%
Health Service
11%
Immunity
22%
Injury
13%
Leukemia Cell
18%
Logistic Regression Analysis
25%
Macrophage
13%
Malignant Neoplasm
21%
Melanoma
22%
Meta-Analysis
34%
Microbiome
22%
Minimally Invasive Procedure
13%
Muscle Invasive Bladder Cancer
34%
Neoadjuvant Chemotherapy
11%
Neonates
12%
Neoplasm
41%
Nerve Cell Differentiation
14%
Non Muscle Invasive Bladder Cancer
22%
Primary Health Care
21%
Proportional Hazards Model
16%
Prostate Cancer
11%
Recurrent Disease
19%
Squamous Cell Carcinoma
11%
Systematic Review
34%
Transcription Factors
36%
Transitional Cell Carcinoma
19%
Transurethral Resection
25%
Ureter Injury
22%
Urethroplasty
22%
Urinary Tract Infection
22%
Urologic Surgery
13%
Urologist
25%
Immunology and Microbiology
Antibacterial Activity
11%
Cadherin
11%
Cell Cycle
17%
Cell Cycle Arrest
11%
Cell Growth
22%
Cell Proliferation
24%
Cycline
11%
Cytotoxic Lymphocyte
11%
Endoplasmic reticulum
11%
Enhancer Region
49%
Fibrinogen
12%
Gene Expression
17%
Glucose Blood Level
11%
Growth Regulation
11%
Gut Microbiome
15%
Hairless
11%
Human Tissue
11%
Immunity
22%
Inflammation Response
13%
Initiation Factor 4E
11%
Initiation Factor 4E Binding Protein 1
11%
Leukemia Cell
12%
Macrophage
25%
MAPK Signaling
11%
Microbiome
34%
Microflora
11%
Mouse Model
12%
Multi-Omics
11%
Muscle
13%
Mycoplasma pneumoniae
11%
Neuroblastoma Cell
35%
Normal Human
11%
Oncogene
23%
P53
11%
Programmed Cell Death
29%
Prostate
11%
Protein Degradation
11%
Protein Family
11%
RNA Polymerase
11%
RNA Sequencing
34%
Secretome
11%
Skin Cell
11%
Taxon
14%
Transcription Factors
37%
Transcriptome
13%
Ubiquitination
32%
Ubiquitins
17%
Viral Disease
11%
Western Blot
13%
Xenograft
35%
